| P50 | author | Justyna Paprocka | Q88034304 |
| P2093 | author name string | Beata Rzepka-Migut | |
| P2860 | cites work | Posture influences melatonin concentrations in plasma and saliva in humans | Q72407653 |
| | Influence of chronic beta-adrenoreceptor blocker treatment on melatonin secretion and sleep quality in patients with essential hypertension | Q72549617 |
| | Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans | Q73049101 |
| | Morning urinary assessment of nocturnal melatonin secretion in older women | Q73336273 |
| | Pulsatile patterns of melatonin secretion in patients with gonadotropin-releasing hormone deficiency: effects of testosterone treatment | Q73410816 |
| | Roles of intensity and duration of nocturnal exercise in causing phase delays of human circadian rhythms | Q73745951 |
| | Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin | Q73894781 |
| | Creatinine is an appropriate reference for urinary sulphatoxymelatonin of laboratory animals and humans | Q74173037 |
| | Neurohypophysial hormone and melatonin secretion over the natural and suppressed menstrual cycle in premenopausal women | Q77600867 |
| | Modulation of serum concentrations of melatonin by carbamazepine and valproate | Q79933918 |
| | Diurnal variation in the salivary melatonin responses to exercise: relation to exercise-mediated tachycardia | Q83602530 |
| | Melatonin secretion in children with epilepsy | Q85296540 |
| | Evaluation of Plasma Melatonin Levels in Children With Afebrile and Febrile Seizures | Q87241505 |
| | Spectral Tuning of White Light Allows for Strong Reduction in Melatonin Suppression without Changing Illumination Level or Color Temperature | Q89468815 |
| | Ocular and systemic melatonin and the influence of light exposure | Q90734883 |
| | Circadian Rhythm Disturbances in the Blind | Q90795564 |
| | Melatonin and its anti-glioma functions: a comprehensive review | Q91053229 |
| | Influence of Exercise Time of Day on Salivary Melatonin Responses | Q91220395 |
| | Melatonin as a Hormone: New Physiological and Clinical Insights | Q91445507 |
| | Melatonin expression in periodontitis and obesity: An experimental in-vivo investigation | Q95580245 |
| | Individual differences in the amount and timing of salivary melatonin secretion | Q23913514 |
| | Calculating the dim light melatonin onset: the impact of threshold and sampling rate | Q23922513 |
| | Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression | Q24651053 |
| | An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans | Q28346116 |
| | Sex differences in phase angle of entrainment and melatonin amplitude in humans | Q28389480 |
| | Sex differences in the circadian profiles of melatonin and cortisol in plasma and urine matrices under constant routine conditions | Q28391241 |
| | Estimating the dim light melatonin onset of adolescents within a 6-h sampling window: the impact of sampling rate and threshold method | Q28397192 |
| | Measuring and using light in the melanopsin age. | Q30361752 |
| | Novel stable fluorophore, 6-methoxy-4-quinolone, with strong fluorescence in wide pH range of aqueous media, and its application as a fluorescent labeling reagent | Q30979645 |
| | Normative data on the daily profile of urinary 6-sulfatoxymelatonin in healthy subjects between the ages of 20 and 84. | Q31035758 |
| | Monitoring salivary melatonin concentrations in children with sleep disorders using liquid chromatography-tandem mass spectrometry | Q33457890 |
| | Melatonin in circadian sleep disorders in the blind. | Q33543314 |
| | Melatonin in Tuberous Sclerosis Complex Analysis Using Modern Mathematical Modeling Methods | Q33655732 |
| | Urinary 6-sulfatoxymelatonin excretion and aging: new results and a critical review of the literature. | Q33768992 |
| | Influence of beta-blockers on melatonin release | Q33862746 |
| | Daily rhythm in human urinary melatonin | Q34099043 |
| | Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle | Q34188646 |
| | Human melatonin production decreases with age. | Q34190514 |
| | MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential. | Q34384945 |
| | Effects of saliva collection using cotton swabs on melatonin enzyme immunoassay | Q34506894 |
| | Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration | Q34622219 |
| | Prediction of nocturnal plasma melatonin from morning urinary measures | Q48477899 |
| | A new concept for melatonin deficit: on pineal calcification and melatonin excretion | Q48734979 |
| | Afternoon serum-melatonin in sleep disordered breathing | Q48768896 |
| | Phase-shifts in melatonin, 6-sulphatoxymelatonin and alertness rhythms after treatment with moderately bright light at night. | Q48848632 |
| | The mammalian pineal gland: Structure and function | Q49140680 |
| | Human plasma melatonin and urinary 6-sulphatoxy melatonin: studies in natural annual photoperiod and in extended darkness. | Q50547669 |
| | Annual changes in 6-sulphatoxymelatonin excretion in man | Q50568982 |
| | Decrease in melatonin precedes follicle-stimulating hormone increase during perimenopause. | Q51009379 |
| | Can Circadian Dysregulation Exacerbate Migraines? | Q53068714 |
| | Validation of a sensitive direct assay for melatonin for investigation of circadian rhythms in different species. | Q53738764 |
| | Unrestricted evening use of light-emitting tablet computers delays self-selected bedtime and disrupts circadian timing and alertness. | Q55178993 |
| | Non-cotton swab sample collection may not affect salivary melatonin assay results. | Q55363736 |
| | Diurnal Variation of Melatonin Concentration in the Cerebrospinal Fluid of Unanesthetized Microminipig. | Q55431149 |
| | Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders | Q57292688 |
| | Real-Time Detection of Melatonin Using Fast-Scan Cyclic Voltammetry | Q57455620 |
| | Systematic review of light exposure impact on human circadian rhythm | Q57470652 |
| | Suppression of salivary melatonin secretion under 100-Hz flickering and non-flickering blue light | Q57810712 |
| | Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans | Q59009468 |
| | Effect of clonidine on plasma ACTH, cortisol and melatonin in children | Q60585581 |
| | Circadian rhythms of melatonin and peripheral clock gene expression in idiopathic REM sleep behavior disorder | Q62850886 |
| | Melatonin and cortisol in individuals with spinal cord injury | Q63729147 |
| | Alterations in Nocturnal Serum Melatonin Levels In Humans With Growth and Aging* | Q68291626 |
| | Physical exercise at night blunts the nocturnal increase of plasma melatonin levels in healthy humans | Q68653961 |
| | Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol | Q70112069 |
| | Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis | Q70289347 |
| | Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans | Q71632061 |
| | Urinary 6-sulfatoxymelatonin cycle-to-cycle variability | Q71919322 |
| | Visual impairment and circadian rhythm disorders | Q34707752 |
| | Measuring melatonin in humans. | Q34762973 |
| | Measurement of melatonin in body fluids: standards, protocols and procedures | Q35084056 |
| | Gingival, plasma and salivary levels of melatonin in periodontally healthy individuals and chronic periodontitis patients: a pilot study. | Q35548722 |
| | The basic physiology and pathophysiology of melatonin | Q36008982 |
| | Melatonin: possible implications for the postoperative and critically ill patient | Q36396126 |
| | Melatonin receptors in humans: biological role and clinical relevance | Q36417399 |
| | Melatonin: potential functions in the oral cavity. | Q36835794 |
| | Melatonin as a biomarker of circadian dysregulation | Q37344042 |
| | Cellular and molecular mechanisms controlling melatonin release by mammalian pineal glands | Q39468158 |
| | Melatonin in Epilepsy: A New Mathematical Model of Diurnal Secretion | Q39539111 |
| | Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. | Q40536989 |
| | Dysregulation of melatonin metabolism in chronic renal insufficiency: role of erythropoietin-deficiency anemia | Q40932012 |
| | Oral administration and distribution of melatonin in human serum, saliva and urine | Q41377833 |
| | Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans. | Q42117872 |
| | Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs | Q42202053 |
| | The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity | Q42215518 |
| | Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin | Q42218895 |
| | Salivary and gingival crevicular fluid melatonin in periodontal health and disease. | Q43164025 |
| | Daily profiles of salivary and urinary melatonin and steroids in healthy prepubertal boys. | Q43184129 |
| | Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study). | Q43273907 |
| | The durations of human melatonin secretion and sleep respond to changes in daylength (photoperiod). | Q43752107 |
| | Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease | Q43758729 |
| | Melatonin enters the cerebrospinal fluid through the pineal recess | Q43829561 |
| | Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detection | Q44019829 |
| | Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis | Q44293267 |
| | Exercise elicits phase shifts and acute alterations of melatonin that vary with circadian phase | Q44304837 |
| | Determination of endogenous melatonin in the individual pineal glands of inbred mice using precolumn oxidation reversed-phase micro-high-performance liquid chromatography | Q44414188 |
| | Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. | Q44486368 |
| | Quantification of melatonin in human saliva by liquid chromatography-tandem mass spectrometry using stable isotope dilution | Q44530679 |
| | Melatonin levels in periodontal health and disease | Q44547196 |
| | Serum melatonin and urinary 6-sulfatoxymelatonin in major depression | Q44630002 |
| | Immunoassay of melatonin with enzyme-labeled antibodies | Q44856199 |
| | Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans | Q44891533 |
| | Direct determination of endogenous melatonin in human saliva by column-switching semi-microcolumn liquid chromatography/mass spectrometry with on-line analyte enrichment | Q44918727 |
| | Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects | Q46158189 |
| | Diurnal expressions of four subtypes of melatonin receptor genes in the optic tectum and retina of goldfish | Q46309955 |
| | Melatonin from cerebrospinal fluid but not from blood reaches sheep cerebral tissues under physiological conditions | Q46608256 |
| | Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease | Q46613717 |
| | Genetic variability in plasma melatonin in sheep is due to pineal weight, not to variations in enzyme activities | Q47253294 |
| | Melatonin and Angelman Syndrome: Implications and Mathematical Model of Diurnal Secretion | Q47555093 |
| | Differential melatonin alterations in cerebrospinal fluid and serum of patients with major depressive disorder and bipolar disorder | Q47852602 |
| | A preliminary study on the relationships between diurnal melatonin secretion profile and sleep variables in patients emergently admitted to the coronary care unit | Q47962256 |
| | Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging | Q48088440 |
| | Sensitive determination of melatonin by precolumn derivatization and reversed-phase high-performance liquid chromatography | Q48224267 |
| | Complete absence of evening melatonin increase in tetraplegics. | Q48250715 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P921 | main subject | systematic review | Q1504425 |
| P577 | publication date | 2020-03-15 | |
| P1433 | published in | International Journal of Environmental Research and Public Health | Q6051382 |
| P1476 | title | Melatonin-Measurement Methods and the Factors Modifying the Results. A Systematic Review of the Literature | |
| P478 | volume | 17 | |